v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Balance beginning (in shares) at Dec. 31, 2023   145,706,531      
Balance beginning at Dec. 31, 2023 $ 422,507 $ 15 $ 382,854 $ 45,570 $ (5,932)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued upon exercise of stock options (in shares)   585,760      
Common stock issued upon exercise of stock options 83   83    
Vested common stock awards (in shares)   212,633      
Stock-based compensation 2,781   2,781    
Net loss (13,913)     (13,913)  
Other comprehensive (loss) income (3,274)       (3,274)
Ending balance (in shares) at Mar. 31, 2024   146,504,924      
Ending balance at Mar. 31, 2024 408,184 $ 15 385,718 31,657 (9,206)
Balance beginning (in shares) at Dec. 31, 2023   145,706,531      
Balance beginning at Dec. 31, 2023 422,507 $ 15 382,854 45,570 (5,932)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (33,412)        
Other comprehensive (loss) income (4,015)        
Ending balance (in shares) at Jun. 30, 2024   147,210,338      
Ending balance at Jun. 30, 2024 390,638 $ 15 388,412 12,158 (9,947)
Balance beginning (in shares) at Mar. 31, 2024   146,504,924      
Balance beginning at Mar. 31, 2024 408,184 $ 15 385,718 31,657 (9,206)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued upon exercise of stock options (in shares)   499,365      
Common stock issued upon exercise of stock options 158   158    
Vested common stock awards (in shares)   206,049      
Stock-based compensation 2,536   2,536    
Net loss (19,499)     (19,499)  
Other comprehensive (loss) income (741)       (741)
Ending balance (in shares) at Jun. 30, 2024   147,210,338      
Ending balance at Jun. 30, 2024 390,638 $ 15 388,412 12,158 (9,947)
Balance beginning (in shares) at Dec. 31, 2024   148,574,227      
Balance beginning at Dec. 31, 2024 338,365 $ 15 393,186 (38,127) (16,709)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued upon exercise of stock options (in shares)   2,116      
Vested common stock awards (in shares)   930,333      
Stock-based compensation 2,289   2,289    
Net loss (26,441)     (26,441)  
Other comprehensive (loss) income 395       395
Ending balance (in shares) at Mar. 31, 2025   149,506,676      
Ending balance at Mar. 31, 2025 314,608 $ 15 395,475 (64,568) (16,314)
Balance beginning (in shares) at Dec. 31, 2024   148,574,227      
Balance beginning at Dec. 31, 2024 338,365 $ 15 393,186 (38,127) (16,709)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (39,188)        
Other comprehensive (loss) income 7,323        
Ending balance (in shares) at Jun. 30, 2025   150,173,853      
Ending balance at Jun. 30, 2025 311,126 $ 15 397,812 (77,315) (9,386)
Balance beginning (in shares) at Mar. 31, 2025   149,506,676      
Balance beginning at Mar. 31, 2025 314,608 $ 15 395,475 (64,568) (16,314)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued upon exercise of stock options (in shares)   185,745      
Common stock issued upon exercise of stock options 57   57    
Vested common stock awards (in shares)   481,432      
Stock-based compensation 2,280   2,280    
Net loss (12,747)     (12,747)  
Other comprehensive (loss) income 6,928       6,928
Ending balance (in shares) at Jun. 30, 2025   150,173,853      
Ending balance at Jun. 30, 2025 $ 311,126 $ 15 $ 397,812 $ (77,315) $ (9,386)